NOVARTIS

Glivec-veenat

GLIVEC contains Drug / Molecule called “Imatinib”. It belongs to a class of medications known as protein-tyrosine kinase inhibitor. For survival, cells need signaling through proteins (signal cascade). Here, the phosphate group is added by tyrosine kinase enzyme, which is used by proteins for signal cascade. Imatinib stops the addition of phosphate group in signal cascade for cancer cells. Hence works as a form of targeted therapy—only cancer cells are killed through the drug's action.

“Veenat” is the generic version of Glivec and both contains same drug “Imatinib”.

Details
Specification

Indication

Glivec is used to treat certain types of leukemia (blood cancer), bone marrow disorders, and skin cancer, or certain tumors of the stomach and digestive system.

Note

Precaution

Glivec is a prescription drug and should be used under proper medical guidance and advice.
Cytopenias (reduction or lack of certain cell elements in blood circulation) might occur.
Severe congestive heart failure and hepatotoxicity may occur.
Upset stomach, nausea, vomiting, diarrhea, headache, joint pain, muscle cramps/pain, dizziness, blurred vision, or drowsiness may occur.

Updated On Oct 17, 2019 by Admin

Strength

100 mg, 400 mg Tablets.

Packing

100 mg: 1*10 Tablets (Strips) 400 mg: 1*10 Tablets (Strips)

Storage

Store at a temperature not exceeding 30 C.

Was this page helpful?

☆ ☆ ☆ ☆ ☆

Not Upto Date Insufficient Helpful

Any suggestions or inputs for Shubhampharma.

Glivec-veenat also available as

NATCO PHARMA LIMITED (INDIA)

Imatinib-veenat

“Imatinib” is the Drug / Molecule content in "Veenat". Imatinib belongs to a class of medications known as protein-tyrosine kinase inhibitor.It works by stopping or slowing the growth of cancer cells (tumours).Imatinib stops the addition of phosphate group in signal cascade for cancer cells. Hence works as a form of targeted therapy—only cancer cells are killed through the drug's action.